WallStreetZenWallStreetZen

NASDAQ: GLUE
Monte Rosa Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Monte Rosa Therapeutics earnings were $6.2M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest GLUE earnings report on Mar 31, 2025 announced Q1 2025 earnings of $46.9M, up 248.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GLUE reported annual earnings of -$72.7M, with -46.3% growth. The next GLUE earnings date is Aug 7, 2025.

GLUE earnings history

Current Revenue
$159.5M
Current Earnings
$6.2M
Current Profit Margin
3.9%

GLUE Return on Equity

Current Company
2.7%
Current Industry
-60.2%
Current Market
31.3%
GLUE's Return on Equity (2.7%)... subscribe to Premium to read more.
High Return on Equity Performance

GLUE undefined

Current Company
1.7%
Current Industry
-2.5%
GLUE is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GLUE announces earnings.

GLUE undefined

Current Company
2.83%
Current Industry
5.8%
GLUE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GLUE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GLUE$17.73M$6.15MN/A$0.08
CRVS-$41.32M-$41.40MN/A-$0.62
ADCT-$96.50M-$149.84MN/A-$1.43
FHTX-$71.61M-$80.44MN/A-$1.36
TNXP-$129.22M-$131.93MN/A-$1,664.44
View Top Biotech Stocks

GLUE earnings dates

Next earnings date
Aug 7, 2025

Monte Rosa Therapeutics Earnings Reports & History FAQ

What were Monte Rosa Therapeutics's earnings last quarter?

Monte Rosa Therapeutics (NASDAQ: GLUE) reported Q1 2025 earnings per share (EPS) of $0.57, up 207.55% year over year. Total GLUE earnings for the quarter were $46.89 million. In the same quarter last year, Monte Rosa Therapeutics's earnings per share (EPS) was -$0.53.

If you're new to stock investing, here's how to buy Monte Rosa Therapeutics stock.

When does Monte Rosa Therapeutics report earnings?

The next GLUE earnings date is Invalid Date. Add GLUE to your watchlist to be reminded of Monte Rosa Therapeutics's next earnings date.

Is Monte Rosa Therapeutics profitable or losing money?

As of the last Monte Rosa Therapeutics earnings report, Monte Rosa Therapeutics is currently profitable. Monte Rosa Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $6.15 million, a 104.55% decrease year over year.

What was GLUE's earnings growth in the past year?

As of Monte Rosa Therapeutics's earnings date in Q3 2025, Monte Rosa Therapeutics's earnings has grown year over year. GLUE earnings in the past year totalled $6.15 million.

What are Monte Rosa Therapeutics's earnings expectations?

The current EPS estimate for Monte Rosa Therapeutics's earnings report in Invalid Date is -$0.38.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.